119 related articles for article (PubMed ID: 36621663)
21. An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library.
Ohyabu N; Hinou H; Matsushita T; Izumi R; Shimizu H; Kawamoto K; Numata Y; Togame H; Takemoto H; Kondo H; Nishimura S
J Am Chem Soc; 2009 Dec; 131(47):17102-9. PubMed ID: 19899793
[TBL] [Abstract][Full Text] [Related]
22. Claudin 7 as a possible novel molecular target for the treatment of pancreatic cancer.
Okui N; Kamata Y; Sagawa Y; Kuhara A; Hayashi K; Uwagawa T; Homma S; Yanaga K
Pancreatology; 2019 Jan; 19(1):88-96. PubMed ID: 30416041
[TBL] [Abstract][Full Text] [Related]
23. Monoclonal Antibody L
Yamada S; Itai S; Nakamura T; Yanaka M; Chang YW; Suzuki H; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2018 Apr; 37(2):110-115. PubMed ID: 29608408
[TBL] [Abstract][Full Text] [Related]
24. A monoclonal antibody specific to the non-epitope region of hepatitis B virus preS1 contributes to more effective HBV detection.
Zhang Z; Li X; Yi W; Li S; Hu C; Chen A
Clin Biochem; 2013 Aug; 46(12):1105-1110. PubMed ID: 23608352
[TBL] [Abstract][Full Text] [Related]
25. Application of anti lung adenocarcinoma monoclonal antibody recognizing cytokeratin-like cytoplasmic antigen for tumor diagnosis.
Shitara K; Fujiwara K; Kusano A; Yamaguchi K; Yoshida H; Sato S; Hanai N
Anticancer Res; 1992; 12(4):1121-9. PubMed ID: 1503402
[TBL] [Abstract][Full Text] [Related]
26. FXYD5 (dysadherin) may mediate metastatic progression through regulation of the β-Na
Lubarski-Gotliv I; Dey K; Kuznetsov Y; Kalchenco V; Asher C; Garty H
Am J Physiol Cell Physiol; 2017 Jul; 313(1):C108-C117. PubMed ID: 28515087
[TBL] [Abstract][Full Text] [Related]
27. [Monoclonal antibody to human pancreatic carcinoma cells].
Koyama S; Fukao K; Osuga T
Gan No Rinsho; 1987 Jan; 33(1):42-7. PubMed ID: 3820599
[TBL] [Abstract][Full Text] [Related]
28. H
Kato Y; Ohishi T; Sano M; Asano T; Sayama Y; Takei J; Kawada M; Kaneko MK
Monoclon Antib Immunodiagn Immunother; 2020 Jun; 39(3):61-65. PubMed ID: 32423281
[TBL] [Abstract][Full Text] [Related]
29. Combination treatment with TRA-8 anti death receptor 5 antibody and CPT-11 induces tumor regression in an orthotopic model of pancreatic cancer.
DeRosier LC; Buchsbaum DJ; Oliver PG; Huang ZQ; Sellers JC; Grizzle WE; Wang W; Zhou T; Zinn KR; Long JW; Vickers SM
Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5535s-5543s. PubMed ID: 17875786
[TBL] [Abstract][Full Text] [Related]
30. In situ allicin generation using targeted alliinase delivery for inhibition of MIA PaCa-2 cells via epigenetic changes, oxidative stress and cyclin-dependent kinase inhibitor (CDKI) expression.
Chhabria SV; Akbarsha MA; Li AP; Kharkar PS; Desai KB
Apoptosis; 2015 Oct; 20(10):1388-409. PubMed ID: 26286853
[TBL] [Abstract][Full Text] [Related]
31. Preclinical evaluation of monoclonal antibody 14C5 for targeting pancreatic cancer.
Vervoort L; Burvenich I; Staelens S; Dumolyn C; Waegemans E; Van Steenkiste M; Baird SK; Scott AM; De Vos F
Cancer Biother Radiopharm; 2010 Apr; 25(2):193-205. PubMed ID: 20423233
[TBL] [Abstract][Full Text] [Related]
32. Functional screen for secreted proteins by monoclonal antibody library and identification of Mac-2 Binding protein (Mac-2BP) as a potential therapeutic target and biomarker for lung cancer.
Sun L; Chen L; Sun L; Pan J; Yu L; Han L; Yang Z; Luo Y; Ran Y
Mol Cell Proteomics; 2013 Feb; 12(2):395-406. PubMed ID: 23184915
[TBL] [Abstract][Full Text] [Related]
33. Identification of the epitope for the epidermal growth factor receptor-specific monoclonal antibody 806 reveals that it preferentially recognizes an untethered form of the receptor.
Johns TG; Adams TE; Cochran JR; Hall NE; Hoyne PA; Olsen MJ; Kim YS; Rothacker J; Nice EC; Walker F; Ritter G; Jungbluth AA; Old LJ; Ward CW; Burgess AW; Wittrup KD; Scott AM
J Biol Chem; 2004 Jul; 279(29):30375-84. PubMed ID: 15075331
[TBL] [Abstract][Full Text] [Related]
34. [Preparation, characterization and potential application of monoclonal antibody 18A4 against AGR2].
Wu ZH; Zhu Q; Gao GW; Zhou CC; Li DW
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jan; 26(1):49-51. PubMed ID: 20056089
[TBL] [Abstract][Full Text] [Related]
35. ImmunoPET Predicts Response to Met-targeted Radioligand Therapy in Models of Pancreatic Cancer Resistant to Met Kinase Inhibitors.
Escorcia FE; Houghton JL; Abdel-Atti D; Pereira PR; Cho A; Gutsche NT; Baidoo KE; Lewis JS
Theranostics; 2020; 10(1):151-165. PubMed ID: 31903112
[No Abstract] [Full Text] [Related]
36. Distribution of LAT1-targeting PET tracer was independent of the tumor blood flow in rat xenograft models of C6 glioma and MIA PaCa-2.
Aoki M; Watabe T; Nagamori S; Naka S; Ikeda H; Kongpracha P; Horitsugi G; Kanai Y; Shimosegawa E; Kanai Y; Hatazawa J
Ann Nucl Med; 2019 Jun; 33(6):394-403. PubMed ID: 30820863
[TBL] [Abstract][Full Text] [Related]
37. Development and characterization of monoclonal antibodies against pancreatic cancer marker hippocalcin-like 1 protein.
Chen Y; Wang X; Zhao P; Zhang Y; Cao B
Monoclon Antib Immunodiagn Immunother; 2014 Feb; 33(1):20-7. PubMed ID: 24555932
[TBL] [Abstract][Full Text] [Related]
38. A novel PET imaging using ⁶⁴Cu-labeled monoclonal antibody against mesothelin commonly expressed on cancer cells.
Kobayashi K; Sasaki T; Takenaka F; Yakushiji H; Fujii Y; Kishi Y; Kita S; Shen L; Kumon H; Matsuura E
J Immunol Res; 2015; 2015():268172. PubMed ID: 25883990
[TBL] [Abstract][Full Text] [Related]
39. Generation and application of monoclonal antibody to human pancreatic carcinoma.
Yuan S; Zhang H; Chen Q
Hybridoma; 1996 Aug; 15(4):289-93. PubMed ID: 8880216
[TBL] [Abstract][Full Text] [Related]
40. Immunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumors.
Wang-Johanning F; Rycaj K; Plummer JB; Li M; Yin B; Frerich K; Garza JG; Shen J; Lin K; Yan P; Glynn SA; Dorsey TH; Hunt KK; Ambs S; Johanning GL
J Natl Cancer Inst; 2012 Feb; 104(3):189-210. PubMed ID: 22247020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
